Latest News & Updates
Breaking News
5 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Pfizer Advances 25-Valent Pneumococcal Vaccine Into Phase 3 After Positive Infant Trial Data
Pfizer moves its 25-valent pneumococcal conjugate vaccine into Phase 3 pediatric trials following positive Phase 2 immunogenicity data across all serotypes.
Pharma Now Editorial Team
Immix Biopharma Achieves 95% Complete Response Rate in NEXICART-2 Phase 2 CAR-T Trial
Immix Biopharma reports 95% CR rate in NEXICART-2, with BLA submission targeted following March 2027 one-year follow-up data readout.
Pharma Now Editorial Team
Cognition Therapeutics Completes FDA Type B Meeting for Zervimesine Registrational Program in DLB Psychosis
Cognition Therapeutics met with FDA on May 20 to align on a registrational program for zervimesine in DLB psychosis; formal minutes expected June 2026.
Pharma Now Editorial Team
Novartis Presents Actinium-Based RLT Phase 1 Data at ASCO 2026 Alongside Pluvicto and Pipeline Updates
Novartis presents Phase 1 actinium-225 RLT and Pluvicto data at ASCO 2026, raising new manufacturing complexity for radiopharmaceutical facilities.
Pharma Now Editorial Team
